Dermatology

Transaction nets Shire a product candidate for treating DEB

BIND Biosciences and Amgen sign agreement for the worldwide development and commercialization of a kinase inhibitor nanomedicine for treating solid tumors

Agreement boasts a total value of $782 million in cash

Acquisition features a total cash value of approximately $230 million, gains Sun Pharmaceutical DUSA's photodynamic therapy platform

Medivir acquires preclinical antiviral programs from Novadex, including hepatitis C and prodrug technologies

Agreement to focus on development, commercialization of JAK inhibitor ASP015K

The great divide between actual science and general public perception—complicated by political controversy and ethical debate—has only grown deeper with every breakthrough or achievement in the quest to use stem cells to regenerate or repair damaged tissue, skin and organs.

HTG Molecular Diagnostics, John Wayne Cancer Institute partner to commercialize melanoma signatures

Development and commercialization agreement to cover five antibodies from Amgen's clinical inflammation portfolio

Sanofi's Genzyme Corp. starts shipping Fabrazyme from new plant

Corcept Therapeutics Inc. gains FDA approval for Cushing's syndrome treatment

Ventana and ACD to co-promote in-situ hybridization assay system that will be automated on Ventana’s DISCOVERY platforms